Ursapharm India Private Limited, a active foreign private limited company, was established on 27 September 2006 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232DL2006FTC154392. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.20 Cr.
It upholds a compliant status. Its leadership includes Uwe Hurth (Director), Boris Georg Roeder (Director), Rohit Jain (Managing Director). Past directors included Uwe Hurth, Dominik Holzer, Jarnail Singh. Its latest AGM occurred on 20 November 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. : A-1, Ground Floor, Fiee Complex, Okhla Industrial Area Phas, E-Ii, New Delhi, Delhi, 110020.
U24232DL2006FTC154392
154392
27 September 2006
₹1.25 Cr
₹1.20 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ursapharm India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uwe Hurth | Director | 05 Dec 2017 | Current |
| Boris Georg Roeder | Director | 27 Sep 2006 | Current |
| Rohit Jain | Managing Director | 01 Apr 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2020 | Past |
| Pramod Abcsdd | Director | 31 Mar 2013 | Past |
| Pramod Abcsdd | Managing Director | 19 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 20 Jun 2020 | Past |
| Pramod Abcsdd | Director | 06 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ursapharm India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.82% decrease. The company also saw a substantial fall in profitability, with a 134.4% decrease in profit. The company's net worth dipped by a decrease of 7.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Ursapharm India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ursapharm India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ursapharm India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ursapharm India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ursapharm India Private Limited last Annual general meeting of members was held on 20 Nov 2024 as per latest MCA records. was completed.
Ursapharm India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Rohit Jain was appointed as a Managing Director was appointed as a Managing Director on 01 Apr 2020 & has been associated with this company since 5 years 8 months . was completed.
Uwe Hurth was appointed as a Director was appointed as a Director on 05 Dec 2017 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
The activity Boris Georg Roeder was appointed as a Director was appointed as a Director on 27 Sep 2006 & has been associated with this company since 19 years 2 months . was completed.
Progress on Ursapharm India Private Limited was registered on 27 Sep 2006 with Roc Delhi & aged 19 years 2 months as per MCA records. was documented.
The CIN of Ursapharm India Private Limited is U24232DL2006FTC154392.
Ursapharm India Private Limited is headquartered at Plot No. : A-1, Ground Floor, Fiee Complex, Okhla Industrial Area Phas, E-Ii, New Delhi, Delhi, 110020.
Ursapharm India Private Limited was incorporated on 27 September 2006.
The current directors of Ursapharm India Private Limited are
The primary industry of Ursapharm India Private Limited is Pharma.
Ursapharm India Private Limited is unlisted.
The authorized capital of Ursapharm India Private Limited is ₹1.25 Cr, and the paid-up capital is ₹1.20 Cr.
The compliance status of Ursapharm India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX